Funder
Österreichische Forschungsförderungsgesellschaft
Steirische Wirtschaftsförderungsgesellschaft
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science
Reference32 articles.
1. FDA. Guidance for industry PAT: a framework for innovative pharmaceutical development, manufacturing, and quality assurance, 2004. http://www.fda.gov/CDER/guidance/6419fnl.pdf.
2. FDA. Pharmaceutical CGMPs for the 21st century - a risk-based approach, FDA Off. Doc. (2004) 32. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/Manufacturing/QuestionsandAnswersonCurrentGoodManufacturingPracticescGMPforDrugs/UCM071836.
3. Badman C, Cooney CL, Florence A, Konstantinov K, Krumme M, Mascia S, Nasr M, Trout BL. Why we need continuous pharmaceutical manufacturing and how to make it happen. J Pharm Sci. 2019;108:3521–3. https://doi.org/10.1016/j.xphs.2019.07.016.
4. Nasr MM, Krumme M, Matsuda Y, Trout BL, Badman C, Mascia S, Cooney CL, Jensen KD, Florence A, Johnston C, Konstantinov K, Lee SL. Regulatory perspectives on continuous pharmaceutical manufacturing: moving from theory to practice: September 26–27, International Symposium on the Continuous Manufacturing of Pharmaceuticals. J Pharm Sci. 2017;106(2017):3199–206. https://doi.org/10.1016/j.xphs.2017.06.015.
5. Plumb K. Continuous processing in the pharmaceutical industry. Chem Eng Res Des. 2005;83:730–8. https://doi.org/10.1205/cherd.04359.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献